Both tirzepatide and semaglutide are prescription medicines used with diet and exercise to treat people with type 2 diabetes or to help people lose and maintain weight loss. Semaglutide has also been approved for cardiovascular risk reduction. They are marketed as Ozempic, Wegovy and Rybelsus (semaglutide) and as Mounjaro or Zepbound (tirzepatide).